Literature DB >> 4596277

Experimental Yersinia enterocolitica infection in mice: kinetics of growth.

P B Carter, F M Collins.   

Abstract

Infection of several strains of laboratory mice with a virulent strain of Yersinia enterocolitica was followed by performing viable bacterial counts on homogenates of selected tissues at intervals after intragastric, aerogenic, or intravenous infection. It is observed that CD-1 mice are more susceptible to Y. enterocolitica infection than either the C(57)B1/6 or B6D2 strains. Development of an enteric infection is dose dependent; less than 5 x 10(7) organisms by mouth yields sporadic, low levels of systemic infection, with many of the animals showing no apparent infection. Increasing the challenge inoculum by a factor of 10 eliminates the variability among the animals, giving rise to an enteric infection in all of the mice that moves quickly to the mesenteric lymph node. The bacterial population in the lymph node multiplies rapidly, and the infection is disseminated to the spleen, liver, and lungs, ultimately killing most of the animals. Exposure to an aerogenic challenge of less than 1,000 organisms resulted in a fulminating pneumonitis with an invariably fatal outcome. Intravenous challenge with 500 organisms caused a rapidly fatal, systemic infection. The growth of the bacteria in the intravenously infected mouse depends upon the temperature at which the challenge inoculum had been grown in vitro. At temperatures below 26 C, the bacteria are cleared from the blood at a slower rate and are more resistant to intracellular killing, as compared to organisms grown at 37 C. This effect results in the inoculum increasing to greater numbers in the tissues in a shorter period of time.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4596277      PMCID: PMC414897          DOI: 10.1128/iai.9.5.851-857.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  [CONTRIBUTION TO THE STUDY OF A NEW GROUP OF GERMS RELATED TO MALASSEZ AND VIGNAL BACILLUS. I. CULTURAL AND BIOCHEMICAL PROPERTIES].

Authors:  H H MOLLARET; A CHEVALIER
Journal:  Ann Inst Pasteur (Paris)       Date:  1964-07

2.  Immunity to enteric infection in mice.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

Review 3.  [Human "Yersinia enterocolitica" infections in 1970, with a report of 642 recent cases. Clinical aspects and epidemiologic perspectives].

Authors:  H H Mollaret
Journal:  Pathol Biol (Paris)       Date:  1971-02

4.  Plague bacillus: survival within host phagocytes.

Authors:  W A Janssen; M J Surgalla
Journal:  Science       Date:  1969-02-28       Impact factor: 47.728

5.  Salmonellosis in orally infected specific pathogen-free C57B1 mice.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

6.  Mechanisms in antimicrobial immunity.

Authors:  F M Collins
Journal:  J Reticuloendothel Soc       Date:  1971-07

7.  New strain of Yersinia enterocolitica pathogenic for rodents.

Authors:  P B Carter; C F Varga; E E Keet
Journal:  Appl Microbiol       Date:  1973-12

8.  Comparative immunogenicity of heat-killed and living oral Salmonella vaccines.

Authors:  F M Collins; P B Carter
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

9.  Mechanisms of acquired resistance in mouse typhoid.

Authors:  R V Blanden; G B Mackaness; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  Host-parasite relations in mouse typhoid.

Authors:  G B Mackaness; R V Blanden; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  41 in total

1.  Animal model of human disease. Yersinia enteritis. Animal model: oral Yersinia enterocolitica infection of mice.

Authors:  P B Carter
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

2.  Influence of Na(+), dicarboxylic amino acids, and pH in modulating the low-calcium response of Yersinia pestis.

Authors:  Robert R Brubaker
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Transport of Ca2+ by Yersinia pestis.

Authors:  R D Perry; R R Brubaker
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

4.  The pathogenicity of Yersinia enterocolitica strains isolated from various sources in four test systems.

Authors:  F Mosimabale; C L Gyles
Journal:  Can J Comp Med       Date:  1982-01

5.  Pathogenecity of Yersinia enterocolitica for mice.

Authors:  P B Carter
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

6.  Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response.

Authors:  Koji Hase; Kazuya Kawano; Tomonori Nochi; Gemilson Soares Pontes; Shinji Fukuda; Masashi Ebisawa; Kazunori Kadokura; Toru Tobe; Yumiko Fujimura; Sayaka Kawano; Atsuko Yabashi; Satoshi Waguri; Gaku Nakato; Shunsuke Kimura; Takaya Murakami; Mitsutoshi Iimura; Kimiyo Hamura; Shin-Ichi Fukuoka; Anson W Lowe; Kikuji Itoh; Hiroshi Kiyono; Hiroshi Ohno
Journal:  Nature       Date:  2009-11-12       Impact factor: 49.962

7.  Comparative study of histopathological alterations during intestinal infection of mice with pathogenic and non-pathogenic strains of Yersinia enterocolitica serotype O:8.

Authors:  A Grützkau; C Hanski; M Naumann
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.

Authors:  M R Scavizzi; J M Alonso; A M Philippon; A M Jupeau-Vessieres; A Guiyoule
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 9.  Factors promoting acute and chronic diseases caused by yersiniae.

Authors:  R R Brubaker
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  Experimental Yersinia pestis infection in rodents after intragastric inoculation and ingestion of bacteria.

Authors:  T Butler; Y S Fu; L Furman; C Almeida; A Almeida
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.